HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 01/11/2013 -- Ascena Retail Group Inc (NASDAQ:ASNA) stock dropped 10.04% to $16.31 after the company said comparable store sales for the combined November and December holiday period declined 2% from last year. As a result, the company lowered its outlook for the fiscal year 2013. Full-year earnings are currently forecast in a range of $1.20 to $1.30 per share. This compares to the previous guidance range of $1.45 to $1.55 per share. Analysts currently expect the company to report full year earnings of $1.53 per share.
Can ASNA Bounce Back? Find Out Here
Molycorp Inc. (NYSE:MCP) fell 22.7 percent to $8.34 with 41,099,200 shares Molycorp Inc’ shares shed one-fourth of its value after the mining firm reported its revenue this year would be lower than expected, citing weak prices and setbacks in production.
Can MCP Jump Again? Find Out Here
Sequenom Inc (NASDAQ:SQNM) decreased 8.0% to $4.20 on a traded volume of 10.69 million shares. The stock was down on the threat of increasing competition. The threat is Illumina Inc said that it would buy privately held Verinata Health for a deal value of $450 million.
Can SQNM Recover After The Recent fall? Find Out Here
Dendreon Corp. (NASDAQ:DNDN) is currently trading at $5.75 up 12.8% in pre-market on 167870 shares traded. DNDN is trading 8.31% above its 50 day moving average and -18.80% below its 200 day moving average. DNDN is -70.07% below its 52-week high and 38.21% above its 52-week low.
Can DNDN Extend Fall? If Yes, How Far It Can Go? Find Out Here
Silver Standard Resources Inc (USA) (NASDAQ:SSRI) decreased 7.59% and closed at $14.0 on a traded volume of 3.76 million shares. The Company announced the pricing of its previously announced offering of convertible senior notes due 2033. The Company increased the offering to $250 million from $D200 million aggregate principal amount.
Is SSRI Showing Any Sign of Buy At The Current Market Price? Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)